Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients

NCT03092544 is registered in ClinicalTrials.gov with Multiple Sclerosis Center of Northeastern New York as lead sponsor.

NCT NCT03092544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03092544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients
Lead sponsor
Multiple Sclerosis Center of Northeastern New York
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2015
Completion date
December 31, 2018
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis